keynote-811: hrqol pembro plus tras and chemo in first-line her2 advanced gastric cancer
Published 6 months ago • 139 plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
1:40
keynote-811: trastuzumab chemotherapy with or without pembrolizumab for her2 g/gej cancer
-
1:04
panthera: pembrolizumab, trastuzumab, and chemotherapy in her2 advanced gastric cancer
-
4:35
keynote-062: pembrolizumab vs. chemo in 1l advanced gastric cancer
-
2:39
first line immunotherapy/chemotherapy in her2- gastric cancer in japan
-
6:21
pembrolizumab plus trastuzumab and chemotherapy for her2 metastatic gastric or gastroesophageal...
-
3:12
advances in her2-targeted therapies for gastric cancer
-
8:01
innovation: chemotherapy with trastuzumab and pertuzumab in her2 gastric cancer
-
1:43
gasther2: trastuzumab for advanced gastric cancer
-
1:08
dr. chung on the rationale of the keynote-811 trial in her2 gastric cancer
-
3:57
pembrolizumab plus 5-fu and cisplatin for first-line treatment in...
-
30:31
gastroesophageal cancer: current positioning of immunotherapy
-
35:36
personalized treatment of advanced her2-negative gastric or gastroesophageal junction cancer
-
1:18:52
her2-positive gastrointestinal cancers: new evidence and practical guidance with targeted agents
-
22:39
gastric cancer: update on first-line therapies
-
1:07:30
personalizing gastric cancer care with her2-targeted and other novel therapies
-
0:49
dr. bang on pembrolizumab for advanced gastric cancer
-
5:46
mahogany: margetuximab in gastric cancer
-
58:37
2021 international gastric cancer educational symposium - session 3
-
3:14
keynote-062 study: pembrolizumab as treatment for advanced gastroesophageal junction and gastric...